Exforge and Victoza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Exforge (amlodipine besylate; valsartan) and Victoza (liraglutide). Common drug interactions include vulvovaginal mycotic infection among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Exforge and Victoza. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.



On Jul, 19, 2026

68 people who take Exforge and Victoza together, and have interactions are studied.

Exforge and Victoza drug interactions.

What are the common drug interactions of Exforge and Victoza, by gender? *:

female:

  1. Vulvovaginal mycotic infection (vulvovaginal fungal infection)
  2. Wheezing (a high-pitched whistling sound made while you breath)
  3. Pancreatic carcinoma (pancreatic cancer)
  4. Vomiting
  5. Chronic kidney disease
  6. Anuria (failure of the kidneys to produce urine)
  7. Blood creatinine increased
  8. Flushing (the warm, red condition of human skin)
  9. Lactic acidosis (low ph in body tissues)
  10. Pain

male:

  1. Weight decreased
  2. Pancreatitis (inflammation of pancreas)
  3. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  4. Chest pain
  5. Dizziness
  6. Fatigue (feeling of tiredness)
  7. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
  8. Diabetic enteropathy (disease of the intestinal tract due to diabetes)
  9. Metastases to liver (cancer spreads to liver)
  10. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)

What are the common drug interactions of Exforge and Victoza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood creatinine increased
  2. Septic shock (shock due to blood infection)

40-49:

  1. Vomiting
  2. Anuria (failure of the kidneys to produce urine)
  3. Chronic kidney disease
  4. Lactic acidosis (low ph in body tissues)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Blood creatinine increased
  7. Cerebral infarction (less blood supply to brain resulting tissue damage)
  8. Dyspnoea (difficult or laboured respiration)
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Injury

50-59:

  1. Chronic kidney disease
  2. Cardiac arrest
  3. Dizziness
  4. Pancreatic carcinoma (pancreatic cancer)
  5. Pancreatitis acute (sudden inflammation of pancreas)
  6. Weight decreased
  7. Diabetic enteropathy (disease of the intestinal tract due to diabetes)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Acute respiratory failure
  10. Cardiac failure

60+:

  1. Weight decreased
  2. Pancreatitis (inflammation of pancreas)
  3. Vomiting
  4. Metastases to liver (cancer spreads to liver)
  5. Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Abdominal infection
  8. Arthralgia (joint pain)
  9. Bladder cancer
  10. Blood creatinine increased

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 22 people, 32.35%
  2. High Blood Pressure: 19 people, 27.94%
  3. Pain: 13 people, 19.12%
  4. High Blood Cholesterol: 10 people, 14.71%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 11.76%
  6. Gout (uric acid crystals building up in the body): 6 people, 8.82%
  7. Stress And Anxiety: 5 people, 7.35%
  8. Infection: 5 people, 7.35%
  9. Asthma: 5 people, 7.35%
  10. Oedema (fluid collection in tissue): 4 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge and Victoza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Exforge and Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exforge and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Victoza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; valsartan and liraglutide (the active ingredients of Exforge and Victoza, respectively), and Exforge and Victoza (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: